HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation [Seeking Alpha]
HilleVax, Inc. (NASDAQ: HLVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) [Yahoo! Finance]